Literature DB >> 21641038

Sustained trilineage hematopoietic recovery in a patient with refractory anemia, del(13)(q12q22), and paroxysmal nocturnal hemoglobinuria-type cells treated with immunosuppressive therapy.

Ikumi Kasahara, Mitsufumi Nishio, Tomoyuki Endo, Katsuya Fujimoto, Takao Koike, Naomi Sugimori, Takamasa Katagiri, Shinji Nakao.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21641038     DOI： 10.1016/j.leukres.2011.05.007

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  1 in total

1.  Favorable outcome of patients who have 13q deletion: a suggestion for revision of the WHO 'MDS-U' designation.

Authors:  Kohei Hosokawa; Takamasa Katagiri; Naomi Sugimori; Ken Ishiyama; Yumi Sasaki; Yu Seiki; Aiko Sato-Otsubo; Masashi Sanada; Seishi Ogawa; Shinji Nakao
Journal:  Haematologica       Date:  2012-06-11       Impact factor: 9.941
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.